麻豆传媒

听has听set the next intake date for funding applications in听鈥媡heir听rolling, open call process. BioCanRx builds听on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials.听鈥婽he network is听strengthening Canada's ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.
As an open call, this opportunity听is open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

LOIs are now being accepted听for the鈥嬏齠our research programs:

路听听听听听听听听听Clinical Trials Program
路听听听听听听听听听Enabling Studies Program
路听听听听听听听听听Catalyst Program
路听听听听听听听听听Clinical, Social and Economic Impact Program

If you have questions regarding your eligibility (or that of your institution) or how your project would fit within

鈥婤颈辞颁补苍搁虫's research program, you are encouraged to contact听Dr. Kelley Parato, Director of Scientific Affairs at BioCanRx.
听
Important Dates:
The next intake deadline is听November 9, 2016, by听11:59 p.m. EDT.

Contact information:听
For more information, see the听听at the BioCanRx website or contact:
Dr. Kelley Parato
Tel:听613-739-6595

Email:听keparato@biocanrx.com